Entegris Inc. filings document formal disclosures for a Nasdaq-listed supplier of advanced materials and process solutions to semiconductor and high-technology industries. Recent Form 8-K reports cover quarterly operating results, Regulation FD exhibits, cash dividend declarations, senior finance leadership appointments, amendments to credit and guaranty arrangements, and changes to governing documents.
Proxy materials and governance filings describe director elections, executive compensation, stockholder voting matters, and amendments to the certificate of incorporation and by-laws, including the replacement of supermajority voting requirements with a majority-of-outstanding-shares standard. The filings also identify common stock registered under the Securities Exchange Act and related board and stockholder actions.
ENTEGRIS INC (ENTG) reported an insider equity transaction by President & CEO David Reeder. On 2026-08-18, Reeder had 5,386 shares of common stock automatically withheld at $150.27 per share to satisfy tax withholding obligations upon settlement of restricted stock units. Following this tax-withholding disposition, Reeder directly owned 91,821 shares of Entegris common stock.
ENTEGRIS INC (ENTG) executive Olivier Blachier, President, Materials Solutions, exercised employee stock options for 2,000 shares of common stock at a conversion price of $80.71 per share and sold 2,000 shares at $160.66 per share. The option exercise reduced derivative holdings, leaving 3,972 options outstanding, and the sale was executed under a Rule 10b5-1 Trading Plan.
Entegris Inc. senior vice president and general counsel Joseph Colella reported an option exercise and same-day sale of common stock. On 2026-08-13, he exercised 3,916 Employee Stock Options awarded under the Entegris, Inc. 2020 Stock Plan at an exercise price of $98.11 per share, converting them into 3,916 shares of common stock. That same day, he sold 3,916 common shares at a weighted average price of $164.48 per share, with individual sale prices ranging from $164.29 to $164.66. The option was fully vested at the time of exercise and was originally granted in consideration of services as an employee.
Issuer ENTG received a notice from Olivier Blachier regarding a planned sale of restricted common stock under Rule 144. The filing lists 2,000 shares of common stock to be sold on or about 08/14/2026 on NASDAQ, tied to a stock option exercise funded in cash.
The disclosure also notes that during the past three months, on 05/14/2026, Blachier sold 2,000 shares of common stock for an aggregate amount of $280,088.00. This is a procedural notice of potential resale by an affiliate or insider rather than a capital-raising transaction by the company.
Joseph M. Colella filed to sell up to 3,916 shares of ENTG common stock through Fidelity Brokerage Services LLC on or after 08/13/2026, to be issued from a stock option exercise paid in cash. The planned sale has an indicated value of $644,103.66. Colella also reported selling 6,326 shares of common stock on 05/14/2026 for proceeds of $886,718.20.
ENTEGRIS INC senior vice president of global human resources Susan G. Rice reported a sale of 2,062 shares of common stock on 2026-08-11 in a sale categorized as an open market or private transaction at $149.52 per share. Following this transaction, she directly holds 66,976.004 shares of Entegris common stock.
Entegris, Inc. affiliate Susan Rice filed to sell common stock under Rule 144. The notice lists a planned sale of 2,062 common shares through Fidelity Brokerage Services, with an aggregate market value of $308,310.24, to be sold on or after August 11, 2026 on NASDAQ.
The filing also notes prior issuances from restricted stock vesting in 2021 and 2024 used as compensation, and a separate sale on May 15, 2026 of 19,893 common shares for $2,642,659.97 in the preceding three months.
Entegris, a supplier of advanced materials and purity solutions for semiconductor manufacturing, reported stronger results for the quarter ended June 27, 2026. Net sales were $883.2 million, up from $792.4 million, and net income rose to $93.6 million, with diluted EPS of $0.61 versus $0.35 a year earlier. For the first six months, net sales were $1,695.1 million and net income $185.6 million, with diluted EPS of $1.21 versus $0.76.
Gross margin improved to 47.6% from 44.4%, helped by higher volumes and a change in estimated useful lives of certain assets, which reduced six‑month depreciation by $37.7 million and increased net income by about $23.3 million, or $0.15 per diluted share. APS segment sales grew 17% in the quarter to $514.6 million, with segment profit up to $150.9 million, while MS segment sales rose 5% to $371.3 million. Cash from operations increased to $339.2 million for the first half, capital spending fell to $80.8 million, and the company repaid $250.0 million of term loan debt, lowering total debt, net, to $3,456.0 million. Entegris maintained a quarterly dividend of $0.10 per share and expanded its undrawn revolving credit facility to $750.0 million, extending its maturity to 2031.
ENTEGRIS INC reported an insider ownership update by Executive Chair Bertrand Loy on a Form 4. The submission lists no purchases, sales, option exercises, or other transactions in Entegris securities, and the structured data shows no share holdings or derivative positions for this report.
BRUGGEWORTH ROBERT A reported acquisition or exercise transactions in this Form 4 filing.
Entegris director Robert A. Bruggeworth received a grant of 1,329 Restricted Stock Units on August 3, 2026 under the Entegris, Inc. 2020 Stock Plan for independent directors. The RSUs, payable solely in common stock, vest in full on the earlier of the grant’s anniversary or the company’s 2027 annual meeting, giving him reported direct holdings of 1,329 common shares underlying this award.